These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 35507826)
1. Wu X; Ge L; Shen G; He Y; Xu Z; Li D; Mu C; Zhao L; Zhang W ACS Appl Mater Interfaces; 2022 May; 14(19):21848-21859. PubMed ID: 35507826 [TBL] [Abstract][Full Text] [Related]
2. Silk fibroin-based embolic agent for transhepatic artery embolization with multiple therapeutic potentials. Shi L; Li D; Tong Q; Jia G; Li X; Zhang L; Han Q; Li R; Zuo C; Zhang W; Li X J Nanobiotechnology; 2023 Aug; 21(1):278. PubMed ID: 37598140 [TBL] [Abstract][Full Text] [Related]
3. Biodegradable Pang F; Li Y; Zhang W; Xia C; He Q; Li Z; Xiao L; Song S; Dong P; Zhou H; Shao T; Cai H; Li L Adv Healthc Mater; 2020 Jul; 9(13):e2000028. PubMed ID: 32431090 [TBL] [Abstract][Full Text] [Related]
4. Microfluidic Controllable Preparation of Iodine-131-Labeled Microspheres for Radioembolization Therapy of Liver Tumors. Jiang QR; Pu XQ; Deng CF; Wang W; Liu Z; Xie R; Pan DW; Zhang WJ; Ju XJ; Chu LY Adv Healthc Mater; 2023 Aug; 12(21):e2300873. PubMed ID: 37265189 [TBL] [Abstract][Full Text] [Related]
5. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. Teyateeti A; Mahvash A; Long J; Abdelsalam M; Avritscher R; Kaseb A; Odisio B; Ravizzini G; Surasi D; Teyateeti A; Macapinlac H; Kappadath SC World J Gastroenterol; 2021 Dec; 27(47):8166-8181. PubMed ID: 35068861 [TBL] [Abstract][Full Text] [Related]
6. Polymer composite microspheres loading Xiao L; Li Y; Geng R; Chen L; Yang P; Li M; Luo X; Yang Y; Li L; Cai H Biomater Res; 2023 Nov; 27(1):110. PubMed ID: 37925456 [TBL] [Abstract][Full Text] [Related]
7. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First De La Vega JC; Esquinas PL; Rodríguez-Rodríguez C; Bokharaei M; Moskalev I; Liu D; Saatchi K; Häfeli UO Theranostics; 2019; 9(3):868-883. PubMed ID: 30809314 [TBL] [Abstract][Full Text] [Related]
8. Radioembolization for the treatment of hepatocellular carcinoma. Kim HC Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530 [TBL] [Abstract][Full Text] [Related]
9. The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization. Tong Q; Li R; Wang R; Zuo C; Li D; Jia G; Peng Y; Li X; Yang J; Xue S; Bai Q; Li X Front Bioeng Biotechnol; 2022; 10():1021499. PubMed ID: 36277378 [TBL] [Abstract][Full Text] [Related]
10. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma. Kallini JR; Gabr A; Salem R; Lewandowski RJ Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186 [TBL] [Abstract][Full Text] [Related]
11. Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma. Zarca K; Mimouni M; Pereira H; Chatellier G; Vilgrain V; Durand-Zaleski I; Clin Ther; 2021 Jul; 43(7):1201-1212. PubMed ID: 34059326 [TBL] [Abstract][Full Text] [Related]
12. Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization. Qian Y; Liu Q; Li P; Han Y; Zhang J; Xu J; Sun J; Wu A; Song S; Lu W ACS Nano; 2021 Feb; 15(2):2933-2946. PubMed ID: 33529007 [TBL] [Abstract][Full Text] [Related]
13. Polydopamine-Coated Radiolabeled Microspheres for Combinatorial Radioembolization and Photothermal Cancer Therapy. Wu M; Zhang L; Shi K; Zhao D; Yong W; Yin L; Huang R; Wang G; Huang G; Gao M ACS Appl Mater Interfaces; 2023 Mar; 15(10):12669-12677. PubMed ID: 36854016 [TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study. Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511 [TBL] [Abstract][Full Text] [Related]
15. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases. Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308 [TBL] [Abstract][Full Text] [Related]
16. Ultrastable PLGA-Coated Jin S; Huang J; Dong Y; Hu D; Sun J; Li Z; Zhong BY; Liu Z; Zhu R; Wang G Mol Pharm; 2024 Jul; 21(7):3407-3415. PubMed ID: 38822792 [TBL] [Abstract][Full Text] [Related]
17. In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? El Fouly A; Ertle J; El Dorry A; Shaker MK; Dechêne A; Abdella H; Mueller S; Barakat E; Lauenstein T; Bockisch A; Gerken G; Schlaak JF Liver Int; 2015 Feb; 35(2):627-35. PubMed ID: 25040497 [TBL] [Abstract][Full Text] [Related]
19. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion. Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342 [TBL] [Abstract][Full Text] [Related]
20. Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma. Syed M; Shah J; Montazeri SA; Grajo JR; Geller B; Toskich B Abdom Radiol (NY); 2021 May; 46(5):2182-2187. PubMed ID: 33216180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]